🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the safety and tolerability of daily ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00630643
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
DEFEND-2 is a Phase 3 confirmatory study for the Phase 3 DEFEND-1 study. Th...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-17
Trial ID
NCT01123083
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
The purpose of the study is to evaluate whether single-agent Elranatamab (P...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2021-02-02
Trial ID
NCT04649359
Treatments Being Tested
This phase III trial studies how well blinatumomab works in combination wit...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2019-07-03
Trial ID
NCT03914625
Treatments Being Tested
This randomized phase III trial studies combination chemotherapy with blina...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-05-19
Trial ID
NCT02003222
Treatments Being Tested
This is an open-label, intermediate-size patient population expanded access...
Status
Available
Location
Brigham and Women's Hospital
Start Date
TBD
Trial ID
NCT06802328
Treatments Being Tested
In the treatment of Ph-negative (Ph-) B-cell acute lymphoblastic leukemia (...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2024-04-02
Trial ID
NCT06387121
The primary purpose of this study is to determine whether teplizumab (MGA03...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2009-09
Trial ID
NCT00920582